Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. (CLDI) has reported earnings 12 times since Nov 14, 2023. The stock moves an average of ±5.82% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +6.34% (May 15, 2024) and its largest decline was -40.09% (Nov 13, 2024). The next earnings report is predicted for 2026-11-13 (estimated).
Earnings reactions
How CLDI moved on each past earnings report.
Earnings Impact
Total Earnings
12
Avg Abs. Movement
±5.82%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☽ POST | +3.9% | open_in_new |
| May 14, 2026 | ☽ POST | -2.55% | open_in_new |
| Mar 27, 2026 | ☽ POST | -10.39% | open_in_new |
| Nov 13, 2025 | ☽ POST | -1.31% | open_in_new |
Earnings Count
12
Total earnings in dataset
Avg Abs. Movement
±5.82%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
Frequently asked about CLDI earnings
When does Calidi Biotherapeutics, Inc. report earnings next? expand_more
Calidi Biotherapeutics, Inc. (CLDI)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CLDI stock move after earnings? expand_more
Over 12 reports, CLDI has moved an average of ±5.82% the session after earnings, closing higher 50.0% of the time.
What was CLDI's biggest post-earnings move? expand_more
CLDI's largest post-earnings gain on record was +6.34% on May 15, 2024, and its largest decline was -40.09% on Nov 13, 2024.
Where can I find Calidi Biotherapeutics, Inc.'s SEC filings? expand_more
All of Calidi Biotherapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right